Health Archive » August, 2008

Health - August, 2008

149 articles

• Revised DOJ Guidelines Could Spark New Strategies
• Judge Stays Generics Companies' Nexium Cases
• Legionella – Action Vs. Reaction
• Sanofi-Aventis Sues Apotex Over ANDA For Eloxatin
• Judge Drops 2 Patents In Medtronic Catheter Case
• J&J Kept Quiet About Risks Of Antibiotic: Suit
• Pfizer Prevails In Danish Lipitor Case
• AWP Price-Fixing Suit Against McKesson Dismissed
• Pfizer Seeks Emergency Sanctions In Neurontin Suit
• County Can Sue Drugmakers Over Pricing: 9th Circ.
• CMS 2009 Proposed Physician Fee Schedule
• Pfizer To Submit PCB Cleanup Plan To EPA
• King Pharmaceuticals Settles Shareholder Suit
• DOJ Changes Corporate Fraud Guidelines
• Vioxx Judge Caps Legal Fees At 32 Percent
• Judge Says Janssen Alzheimer's Patent Invalid
• New Final Rule Clarifies FDA's View On Preemption
• Breckenridge Must Stop Selling Multivitamin: Judge
• Supplement Tycoon Sentenced To 25 Years
• Smith V. Selma: Guidance For Peer Review Bodies
• Abbott's Appeal, Deal OK'd In Norvir Antitrust Case
• Stryker Sues Government Over 'Oppressive' Subpoena
• Barr Still On The Hook In Ovcon Antitrust Suit
• Judge Rules Against Ortho-McNeil In 2 Ultracet Suits
• MDL Panel Consolidates NuvaRing Liability Cases
• CORRECTED: Class Moves To Stop BMS Changes To AWP Payouts
• Judge Says Wyeth Premarin-Only Suits To Continue
• Bayer, Others To Get Fees, Costs In Abbott Suit
• HHS Proposes Rule For Anti-Abortion Health Workers
• Judge Issues Injunctions In Medical Device Case
• Endo Sues Sandoz Over ANDA For Generic Opana
• Azur Sues Barr Over Plan To Make Generic FazaClo
• Fed. Circ. Affirms Dismissal In Merck Eye Drug Suit
• Byetta Warnings Stir Interest Of Plaintiffs Bar
• Drug Disposal Methods May Get EPA Regulation
• Third Generics Co. Cut From Eli Lilly ADHD Drug Suit
• Assembly Bill 3000 And The POLST Form In Calif.
• Judge Nixes Some Infringement Claims V. Applera
• $300M Malpractice Suit Against Deloitte Lives On
• Ch. 11 Disclosure Approved For Leiner Health
• Flonase Indirect Purchasers Sue SmithKline Beecham
• Applera, Illumina Spar Over DNA Sequencing Patents
• Sanofi Faces Antitrust Suit Over Lovenox Contracts
• Bayer, Abbott Debate Fees In Patent Dispute
• Lawmakers Ask For 10 Years Of Vytorin Records
• Smith & Nephew Didn't Infringe Polymer Patent: Judge
• Medtronic Sues NuVasive Over Spinal Surgery Patents
• Life Sciences Practice: Sidley Austin
• Longs Drug Stores Pushes $2.9B Merger With CVS
• Judge Keeps BMS Securities Suit In Play
• Biolase Hit With Antitrust Suit Over Dental Lasers
• AstraZeneca Wins Victory In Prilosec Patent Battle
• Abbott's Appeal Tentatively OK'd In Norvir Suit
• FDA Issues Byetta Warning In Wake Of Deaths
• Judge Tosses Suit Severed From Medtronic MDL
• Merck Study Was For Marketing: Report
• Wyeth Sues Apotex Over Plans For Generic Effexor
• Fried Frank Confirms Support Staff Layoffs
• Bayer Seeks To Toss Fraud Claims From Trasylol MDL
• Northstar Defendants Move Suit To Fed. Court
• Pressure Products Wins Injunction Against Rival
• Fed. Circ. Draws The Line On DJ Jurisdiction
• Janssen Sues Sandoz Over Alzheimer's Drug Patent
• 2nd Judge Tossed From Contrast Agent Case
• Amgen Anemia Drug Tying Case Hangs By A Thread
• Fed. Circ. Clarifies MedImmune Decision
• Fed. Circ. Favors Dr. In Cordis Patent Suit
• The Impact Of Revisions To The PhRMA Code
• Drugstores Granted Class Status In TriCor Suit
• GSK Objects To Abbott's Proposed Norvir Settlement
• Cordis Infringed Aneurysm Repair Patents: Judge
• Court Ruling Bodes Well For UnitedHealth Settlement
• Biomedical Companies Spar Over Genotyping Patents
• Boston Scientific Recalls Faulty Stents
• GlaxoSmithKline Sales Reps File FLSA Overtime Suit
• NEJM Editors Buck Wyeth, Feds In Amicus Brief
• Dusa Licenses Nicomide To Former Foe
• Shoulder Pump Cases Denied MDL Status
• Medtronic Hit With Suit Over Catheter Balloons
• FTC Clears Air With $6.5M Airborne Settlement
• Judge Refuses To Toss All Claims Against Connetics
• Post-Quanta, Companies Rethink Licensing Strategies
• Savient, Upsher-Smith Settle Oxandrin Patent Dispute
• Judge Finds Watson Infringed Elan's Naprelan Patent
• Medtronic Sues Boston Scientific, Abbott Over Stents
• Boston Scientific Slaps Medtronic With Stent Suit
• Former CareFirst CEO Sues For Severance Pay
• Biovail Sues Sun Over Cardizem ANDA
• Judge Orders Disbursed Payments In Medtronic MDL
• FTC OKs Sun's Taro Buy After Divestitures
• 9th Circ. Rules In Favor Of Gilead Shareholders
• Barr Settles Mirapex, Aggrenox Patent Suits
• McDermott Snags Ph.D. For IP, Life Sciences Groups
• Impax Labs Hit With Patent Suit Over Ultram ANDA
• Sanofi Sues Apotex Over Cancer Treatment
• ImClone To Pay Abbott $17.5M To Settle Erbitux Suits
• Steptoe Hires Product Liability Head From WilmerHale
• Code Writer Settles Copyright Case For $3M
• 1st Circ. Upholds Dismissal Of Biogen Suit
• FDA Warns Of Drug Pair's Muscle Injury Link
• Suit Claims Pfizer Hid Chantix Side Effects
• Arnold & Porter Nabs FDA Associate Chief Counsel
• Emory U. Wins Patent Fight Against Nova Biogenetics
• DOJ Targets Boston Scientific With Stent Subpoena
• Firms Awarded Big Fees In Biovail Securities Case
• Abbott Glucose Strip Patent Invalid: Jury
• Covidien To Pay $15M As Part Of Tyco Settlement
• Crowell Adds IP Partner With Stent Trial Experience
• Ex-Biopure Head Settles SEC Blood Substitute Case
• Health Net To Pay Up To $261M To Settle Suits
• Boston Scientific Tries To Invalidate Wall Stent Patent
• Some Counterclaims Dropped From Coreg Patent Suit
• Medtronic, Others Hit With Cutting Tool Patent Suit
• 2 More National Century Execs Sentenced For Fraud
• Reining In The Scope Of Safe Harbor
• Pfizer, Apotex Agree To Settle Over Lipitor
• AG Says Contractor Health Coverage Mandate Legal
• Walgreens Sues CVS Over Mail-Order Rx Market
• Eppendorf, Bio-Rad Drop Suits Against Each Other
• Expert Issues Dire Report On Drug Approval Process
• River's Edge, Everett Settle Pregnancy Vitamin Suit
• J&J Unit Recalls 44,000 Vials Of Anemia Drug
• Serviceable Notion: Removal By Resident Defendants
• Ex-National Century Execs Sentenced In Fraud Case
• Lonza, EPA Settle False Disinfectant Label Claims
• 5th Circ. Reversal Of Poliner Restores Order
• Suit Says Nixing Bus Ad Ran Over Union's Rights
• Implant Maker Zimmer Hit With Securities Fraud Suit
• Juries May Review Future Damages In Patent Suits
• DOJ Subpoenas Cordis Over Bile-Duct Stent Marketing
• Fed. Circ. Nixes 'Safe Harbor' Appeal
• U.S., D.C. Settle City Hospital's False Medicare Claims
• Bayer Fires New Round In Contraceptive Pill Fight
• FDA Issues New Conflict Of Interest Guidelines
• Actavis Recalls Dozens Of Drugs After FDA Inspection
• N.J. High Court Makes Exception For Suing Counsel
• Attys. Battle To Sway Jury In Glucose Strip Patent Trial
• DOJ Asks Wyeth For Protonix Data
• Mirapex Gambler Wins $8M In Court
• Eating Disorders Coverage Suit Against BCBS Survives
• Barbs Traded Over Glucose Strip Patent Royalties
• Celebrex Plaintiffs Must Comply With 'Lone Pine' Order
• Pharma Suits Still Low Despite ITC Surge
• Senate Questions Proposed Pa. Health Merger
• Firms, Bar Recover From Kickback Prosecution
• House Asks FDA For Vytorin Study Analysis
• U.K. Judge Rejects Gene Sequence Patent
• AMS Sues Laser Peripherals Over Prostate Treatment
• Biologics Litigation On The Upswing